Sign in
AVY

Aleksey V. Yefremov

Managing Director and Senior Chemicals Equity Research Analyst at Keybanc Capital Markets,inc /oh/

New York, New York, United States

Aleksey V. Yefremov is a Managing Director and Senior Chemicals Equity Research Analyst at KeyBanc Capital Markets Inc., where he specializes in chemicals sector coverage for major companies such as Celanese and Element Solutions. He has issued over 700 price targets and ratings across 20 stocks, maintaining a price target met ratio of 58% and an average potential upside of over 26%, with standout recommendations such as a rapid profitable call on Spotify. Yefremov joined KeyBanc in December 2019 after five years covering chemicals at Nomura Securities and earlier analyst roles at BofA/Merrill Lynch; his career began as an Analysis Specialist at Accenture. He holds an MBA from Kellogg School of Management, a master's degree in finance from St. Petersburg University of Economics and Finance, and the Series 7, 63, 86, and 87 securities licenses, with FINRA registration.

Aleksey V. Yefremov's questions to Corteva (CTVA) leadership

Question · Q3 2025

Aleksey V. Yefremov asked about Corteva's crop protection (CP) business, specifically the competitive positioning of the 35% of the portfolio that is not classified as 'differentiated,' given the increasingly competitive market.

Answer

EVP of Crop Protection Business Unit Robert King clarified that the 'not differentiated' portion of the portfolio does not equate to commodity generics. He explained that these are still formulated products, typically positioned at a lower price point within the brand ladder, offering value to farmers. King emphasized that Corteva's strategy, as an innovation company, is to focus on the upper end of the market and avoid playing in commodity generic molecules, aiming for premium products that add value.

Ask follow-up questions

Fintool

Fintool can predict Corteva logo CTVA's earnings beat/miss a week before the call

Question · Q3 2025

Aleksey V. Yefremov asked for clarification on the remaining 35% of Corteva's Crop Protection portfolio that is not classified as 'differentiated,' inquiring about their competitive positioning in a potentially more competitive market.

Answer

EVP of Crop Protection Business Unit Robert King explained that the non-differentiated 35% of the portfolio consists of formulated products that are not commodity generics but offer value at a lower price point than premium differentiated products. He reiterated Corteva's strategy to focus on the upper end of the market as an innovation company, avoiding commodity generic molecules.

Ask follow-up questions

Fintool

Fintool can write a report on Corteva logo CTVA's next earnings in your company's style and formatting

Aleksey V. Yefremov's questions to RPM INTERNATIONAL INC/DE/ (RPM) leadership

Question · Q1 2026

Aleksey V. Yefremov questioned RPM's growth algorithms, asking if the current year's guidance (single-digit sales, high single-digit EBIT) reflects a normal year or temporary challenges, and if higher incremental margins are expected in a more typical growth environment, also inquiring about Consumer pricing intentions.

Answer

Frank Sullivan, Chairman and CEO, stated that the current year is not normal due to tariff uncertainty, raw material costs, stalled capital investment, and SG&A inflation. He believes that in a normal environment, 7% revenue growth should yield mid-teens earnings growth, and RPM's strategy is to outperform when markets improve. He confirmed that price increases enacted at the end of Q1 will benefit the Consumer Group in Q2.

Ask follow-up questions

Fintool

Fintool can predict RPM INTERNATIONAL INC/DE/ logo RPM's earnings beat/miss a week before the call

Let Fintool AI Agent track Aleksey V. Yefremov for you

Get briefed when they ask questions on calls

Best AI Agent for Equity Research

Performance on expert-authored financial analysis tasks

Fintool-v490%
Claude Sonnet 4.555.3%
o348.3%
GPT 546.9%
Grok 440.3%
Qwen 3 Max32.7%

Try Fintool for free